Clinical Utility of Whole RNA Sequencing for Fusion Detection in Acute Leukemia
Cells · 08.06.2026 · 15 (12) · 1048
DOI: 10.3390/cells15121048 ↗Kurz gefasst
Fachartikel in der Zeitschrift Cells, online erschienen am 08.06.2026. Verfasst von Namsoo Kim und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Laboratory Medicine, Yonsei University College of Medicine, Severance Hospital, Seoul 03722, Republic of Korea. Hauptthemen laut MEDLINE: Sequence Analysis, RNA, Gene Fusion, Leukemia, Oncogene Proteins, Fusion. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 35 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Research Foundation of Korea.
Abstract (Originalsprache)
Background
Gene fusions play a pivotal role in the pathogenesis and classification of hematologic malignancies. RNA sequencing (RNA-seq) has emerged as a powerful tool for detecting gene fusions; however, many clinical studies have focused on targeted RNA-seq, and optimal parameters for whole transcriptome RNA-seq remain uncertain.
Methods
We retrospectively analyzed whole RNA-seq data from 301 patients diagnosed with acute leukemia between October 2022 and May 2025 to characterize the landscape of pathogenic gene fusions. Fusions were identified using the Arriba algorithm, and subsampling analyses were performed on cases with recurrent fusions to determine the minimum sequencing output required for reliable detection.
Results
Pathogenic gene fusions were identified in 113 of 301 patients (37.5%). Whole RNA-seq detected fusions that were not identifiable by conventional assays, including UBTF::ATXN7L3, and highlighted frequent fusion events, such as ZNF384 rearrangements. Subsampling analysis demonstrated that a sequencing output ≥ 100 million reads (moderate confidence) or ≥300 million reads (high confidence) was sufficient for 100% detection of recurrent fusions.
Conclusions
Whole RNA-seq reliably detects clinically relevant gene fusions in acute leukemia, aligns well with conventional karyotyping results, and surpasses targeted RNA-seq in comprehensiveness. A sequencing output of at least 100 million reads is recommended for clinical fusion detection.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Laboratory Medicine, Yonsei University College of Medicine, Severance Hospital, Seoul 03722, Republic of Korea.
- Aerospace Medical Center, Republic of Korea Air Force, Cheongju 28187, Republic of Korea.
- Department of Laboratory Medicine, Severance Hospital, 50-1 Yonsei-ro, Seodaemun-gu, Seoul 03722, Republic of Korea.
- Department of Laboratory Medicine, Graduate School of Medical Science, Brain Korea 21 PLUS Project, Yonsei University College of Medicine, Seoul 03722, Republic of Korea.
- Department of Laboratory Medicine, Kangbuk Samsung Hospital, Sungkyunkwan University School of Medicine, Seoul 03181, Republic of Korea.
- Dxome Co., Ltd., Seongnam-si 13209, Republic of Korea.
ORCID-Profile: Namsoo Kim, Yu Jin Park, Saeam Shin
Förderung
- National Research Foundation of Korea
Zitieren
APA
Kim, N., Park, Y. J., Min, Y. K., Lim, S., Choi, Y. J., Lee, S. T., Choi, J. R., Kim, H., & Shin, S. (2026). Clinical Utility of Whole RNA Sequencing for Fusion Detection in Acute Leukemia. Cells, 15(12), 1048. https://doi.org/10.3390/cells15121048
Vancouver
Kim N, Park YJ, Min YK, Lim S, Choi YJ, Lee ST, et al. Clinical Utility of Whole RNA Sequencing for Fusion Detection in Acute Leukemia. Cells. 2026;15(12):1048. doi:10.3390/cells15121048
BibTeX
@article{Kim2026,
author = {Kim, Namsoo and Park, Yu Jin and Min, Young Kyu and Lim, Seoyoung and Choi, Yu Jeong and Lee, Seung-Tae and Choi, Jong Rak and Kim, Hongkyung and Shin, Saeam},
title = {Clinical Utility of Whole RNA Sequencing for Fusion Detection in Acute Leukemia},
journal = {Cells},
year = {2026},
volume = {15},
number = {12},
pages = {1048},
doi = {10.3390/cells15121048}
}
EUVIMED